Onconic Therapeutics Inc. Stock Price

KOSDAQ:A476060 Community·₩855.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

A476060 Share Price Performance

₩19,050.00

13550.00 (246.36%)

₩19,050.00

13550.00 (246.36%)

₩19,050.00

Sat, 30 May 26

Share Pricen/a

A476060 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks

2 Rewards

View Full Analysis

Onconic Therapeutics Inc. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 452.85
: 99.98%
: 30.25%
: 0%

View Full Analysis

About A476060

Founded: 2020
Employees: 31
CEO: John Kim
WebsiteView website: onconic.co.kr

Onconic Therapeutics Inc. engages in the research and development of anti-cancer therapy in South Korea. It develops Zastaprazan (OCN-101), a potassium-competitive acid blocker, which is in phase 3 for the treatment of gastric acid related disease; and OCN-201 (JPI-547), an anticancer drug; JP-1366, a treatment for peptic ulcer; and drugs for DDR and immuno-oncology fields. JP-1366, a poly ADP-ribose polymerase inhibitor, which is in phase 1 for the treatment of pancreatic cancer. The company was founded in 2020 and is based in Seoul, South Korea.